Chronic otitis media

disease
On this page

Also known as chronic otitis media (disease)otitis media (disease), chronic

Summary

Chronic otitis media (MONDO:0021204) is a disease and 19 clinical trials. Top therapeutic interventions include dexmedetomidine. A subtype of otitis media — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • ClinVar variants: 1
  • Clinical trials: 19

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namechronic otitis media
Mondo IDMONDO:0021204
ICD-1138010200
SNOMED CT21186006
UMLSC0271441
MedGen75751
Is cancer (heuristic)no

Also known as: chronic otitis media (disease) · otitis media (disease), chronic

Data availability: 1 ClinVar variant.

Disease family

This is a subtype of otitis media. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › auditory system disordermiddle ear disorderotitis mediachronic otitis media

Related subtypes (7): middle ear cholesterol granuloma, non-suppurative otitis media, otosalpingitis, suppurative otitis media, allergic otitis media, infectious otitis media, tympanitis

Subtypes (4): chronic tympanitis, chronic purulent otitis media, chronic eustachian salpingitis, chronic non-suppurative otitis media

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

1 retrieved; paginated sample, class counts are floors:

1 uncertain significance

ClinVarVariant (HGVS)GeneClassificationReview
26793246;XX;t(1;13)(q11.2;p11.2)dnUncertain significancecriteria provided, single submitter

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 19.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified17
PHASE31
PHASE2/PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00271778PHASE3UNKNOWNA Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis Media
NCT01188551PHASE2/PHASE3COMPLETEDDexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
NCT04396145Not specifiedACTIVE_NOT_RECRUITINGThe Effects of Chronic Otitis Surgery on SVV
NCT00189098Not specifiedCOMPLETEDEffectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media
NCT00270660Not specifiedUNKNOWNA Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media
NCT00941993Not specifiedCOMPLETEDAnesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus
NCT01157910Not specifiedUNKNOWNBacterial Assessment of Middle Ear Fluid in Children Undergoing Ventilation Tube Placement Surgery
NCT01251432Not specifiedCOMPLETEDRisk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults
NCT01855425Not specifiedCOMPLETEDCone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
NCT02226718Not specifiedCOMPLETEDValidation of a Questionnaire for Measuring Quality of Life in Patients With Chronic Inflammation of the Middle Ear
NCT02495038Not specifiedCOMPLETEDOptimal Dose of Combination of Rocuronium and Cisatracurium
NCT02716376Not specifiedCOMPLETEDTreatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy
NCT03294421Not specifiedUNKNOWNCombined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy
NCT04374266Not specifiedCOMPLETEDTegmen Defect Management During Mastoidectomy
NCT04423952Not specifiedWITHDRAWNValidity of the French Version of the Quality of Life Questionnaire COMQ12-FR
NCT04864912Not specifiedCOMPLETEDRetrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery
NCT06398899Not specifiedCOMPLETEDSugammadex v.s. Neostigmine/Glycopyrrolate
NCT07149480Not specifiedCOMPLETEDComparison of Postoperative Outcomes of Interlay vs Underlay Graft in Tympanoplasty
NCT07595484Not specifiedCOMPLETEDA Prospective Comparative Study of Dry vs Wet Temporalis Fascia Graft in Tympanoplasty

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
DEXMEDETOMIDINE41